secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001641172-25-023580
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma appoints Jeannine Zimmerman as CFO effective Aug 13, 2025
---------------------------------------------------------------------------

- Jeannine Zimmerman, age 48, appointed CFO effective August 13, 2025.
- She holds a B.S. in accounting from St. Joseph's College; experience includes SEC filings, audit, and SOX 404 testing.
- Prior to appointment, CEO James Nathanielsz had served as both CEO and CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225023580/0001641172-25-023580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225023580/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-023580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer